Ex vivo bone marrow purging with oligonucleotides.
Bergan
R C
RC
Department of Cell and Cancer Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
D000818:Animals; D016465:Bone Marrow Purging; D002451:Cell Compartmentation; D016044:Fusion Proteins, bcr-abl / Q000096:biosynthesis / Q000235:genetics; D016259:Genes, myc; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology; D008247:Lysosomes / Q000378:metabolism; D009369:Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy; D014411:Neoplastic Stem Cells / Q000187:drug effects*; D016376:Oligonucleotides, Antisense / Q000493:pharmacokinetics / Q000633:toxicity; D012333:RNA, Messenger / Q000037:antagonists & inhibitors / Q000378:metabolism; D012334:RNA, Neoplasm / Q000037:antagonists & inhibitors / Q000378:metabolism; D014407:Tumor Cells, Cultured
D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D016044:Fusion Proteins, bcr-abl